V
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99447648
- Mark type
- Design + words
- Filed
- 16 Oct 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science
- Class 005 — Pharmaceuticals: Probiotic pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
- Class 042 — Scientific and technological services: Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic pharmaceutical products, microbe-targeted pharmaceutical products, or host-targeted pharmaceutical products; research in the fields of conducting clinical trials for others, biochemistry, and biotechnology
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals
Owner
- Axial Therapeutics, Inc., Woburn, MA, US
- Axial Therapeutics, Inc., Woburn, MA, US
Prosecution history
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 26 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 26 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 25 Nov 2025 — ASSIGNED TO EXAMINER
- 25 Nov 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 25 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Oct 2025 — NEW APPLICATION ENTERED